INTRODUCTION CASE REPORT

Immunophenotyping of circulating T cells in a mucosal leishmaniasis patient coinfected with HIV
Immunofenotipagem de células T circulantes em um paciente com leishmaniose mucosa coinfectado com HIV Human protection against localized cutaneous leishmaniasis (LCL) due to Leishmania (Viannia) braziliensis (Lb) is dependent on an efficient T helper lymphocyte 1 (Th1) response, whereas susceptibility is associated with an increased Th2 and T regulatory (Treg) profile 1, 2 . Mucosal leishmaniasis (ML) is defined as an uncontrolled Th1-type inflammation of the oropharyngeal region, presenting a disfiguring facial lesion and can occur after unsuccessful healing of a previous LCL 3 . Recent data demonstrate that HIV coinfection is crucial to unbalancing the immune response and could favour the occurrence of reactivated leishmanial lesions 4, 5 . The report discusses some data concerning the anti-Leishmania specific cellular immune response of an HIV + ML patient.
A 36-year-old male from Itaporã City (State of Mato Grosso do Sul, Brazil) was admitted to the Hospital das Clínicas of the Triângulo Mineiro Federal University on December 2009, with a 5-years progressive mucosal lesion on his right septum. At the time of admission, physical examination revealed a septal perforation and a roundish scar on his right ankle originating from an untreated clinically resolved ulcerative lesion 15 years previously. Chest radiography and electrocardiography (ECG) were normal, with no historical record of altered blood pressure or diabetes events among close relatives. The patient reported past illicit drug use. Laboratory analysis revealed negative results for Mycobacterium leprae bacilloscopy, fungi and mycobacteria cultures, serology for Trypanosoma cruzi, hepatitis B and C viruses and Treponema pallidum (FTA-Abs). Serology for HIV was repeatedly positive (ELISA), with a viral load of 25560 RNA copies/ml, a CD4 3 . A tissue fragment collected from the scar on the right ankle revealed negative histology for fungi and mycobacteria, while a fragment from the nasal septum showed chronic granulomatous inflammation and amastigote forms of Leishmania sp. Computerized tomography revealed a concentric mucosal hypertrophy of the ethmoidal and maxillary sinuses and the presence of fluidic discharge in the inferoventral portion of the nasal septa and the inferior turbinate.
Venous blood was collected before any treatment regimen began. Peripheral blood mononuclear cells (PBMC) were separated using Ficoll-Paque TM Plus gradient (GE Health Care, Uppsala, Sweden) and cultured in RPMI 1640 (GIBCO, Grand Island, NY, USA) medium alone or in the presence of Leishmania (V.) braziliensis antigens (AgLb) in a 5% CO 2 atmosphere at 37ºC for 24h, as described elsewhere Table 1) . Dead cells were omitted by side scatter/forward scatter (SSC/FSC) gating, and isotype-matched control antibodies were used to determine background levels of staining.
After blood sampling, a delayed-type hypersensitivity test (Montenegro skin test) was performed and resulted in a 12mm positive induration. The patient was then followed and treated in accordance with standard Brazilian Ministry of Health clinical practice.
Very little data is available regarding the immunological response in HIV + ML patients. It has been demonstrated that cells from HIV -ML patients present a strong anti-Leishmania specific TNF-α and IFN-γ production, with a concomitant decrease in IL-10 and TGF-β levels 3 . In a late stage AIDS-associated ML patient, the low lymphocyte proliferative response and IFN-γ production were restored after the first specific immunochemotherapy course. Apparently, this restoration was dependent on predominating CD8 + rather than CD4 + responding T cells 6 . Another HIV + /ML case series showed that circulating CD4 + T cell count was < 150 cells/mm 3 and that the leishmaniasis clinical outcome showed strong variability among the patients 5 . To our knowledge, no data is available regarding the effects of early HIV infection on the cytokine profile of ML patients. Here, observation verified that the ML patient responded to AgLb and that this response was dependent on both CD4 + and CD8 + T cells, with increased expression of the CD69 + cellular activating surface marker ( Table 1) . The activation state observed on the CD4 + cells was associated with an increase in the expression of transcription factor Foxp3, characteristic of a Treg cell phenotype, and in intracellular staining of the Th2 cytokine IL-4 in the GATA-3 -subpopulation, which indicates up-regulation in the IL-4R/STAT6 pathway. Concomitantly, a decrease in CD4 + IL-17A + cells was observed. The exact role of the Th17 response in human parasitic diseases remains unclear, but seems to be related to the in situ inflammatory milieu observed in ML patients 7 and could be down-modulated during the course of HIV, favoring parasite evasion and the establishment of infection. Studies by Bottrel et al showed that the CD8 + cell population revealed only a slight increase in IFN-γ intracellular staining following stimulation with Lb antigens, which suggests a secondary role of this cell population in host protection and infection clearance 8 .
These results show the existence of some modulating mechanism in this HIV coinfected ML patient and brings to light some new aspects concerning effector T helper cell involvement during Leishmania (V.) braziliensis infection. Further case-control studies are required to confirm these results. 
